Operating
Amortization
Gilead Sciences Amortization decreased by 0.2% to $596.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.5%, from $599.00M to $596.00M. Over 4 years (FY 2021 to FY 2025), Amortization shows an upward trend with a 8.6% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2013
Last reportedQ1 2026May 7, 2026
How to read this metric
Higher amortization often signals significant past M&A activity or heavy investment in intellectual property, whereas lower levels suggest fewer intangible assets being written off.
Detailed definition
This represents the non-cash charge associated with the write-down of intangible assets, such as patents, software, or a...
Peer comparison
Standard for technology companies with significant intellectual property portfolios; peers often report this separately from tangible depreciation.
Metric ID:
operating_adjustment_for_amortizationHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $440.00M | $441.00M | $445.00M | $445.00M | $445.00M | $445.00M | $445.00M | $546.00M | $598.00M | $598.00M | $597.00M | $596.00M | $596.00M | $596.00M | $598.00M | $599.00M | $598.00M | $596.00M | $597.00M | $596.00M |
| QoQ Change | — | +0.2% | +0.9% | +0.0% | +0.0% | +0.0% | +0.0% | +22.7% | +9.5% | +0.0% | -0.2% | -0.2% | +0.0% | +0.0% | +0.3% | +0.2% | -0.2% | -0.3% | +0.2% | -0.2% |
| YoY Change | — | — | — | — | +1.1% | +0.9% | +0.0% | +22.7% | +34.4% | +34.4% | +34.2% | +9.2% | -0.3% | -0.3% | +0.2% | +0.5% | +0.3% | +0.0% | -0.2% | -0.5% |
Range$440.00M – $599.00M
CAGR+6.6%
Avg YoY Growth+8.5%
Median YoY Growth+0.4%
Amortization at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's amortization?
- Gilead Sciences (GILD) reported amortization of $596.00M in Q1 2026.
- How has Gilead Sciences's amortization changed year-over-year?
- Gilead Sciences's amortization decreased by 0.5% year-over-year, from $599.00M to $596.00M.
- What is the long-term trend for Gilead Sciences's amortization?
- Over 4 years (2021 to 2025), Gilead Sciences's amortization has grown at a 8.6% compound annual growth rate (CAGR), from $1.72B to $2.39B.
- What does amortization mean?
- The non-cash expense related to the gradual write-down of intangible asset values.